In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Synthetic Biology And The Computerization Of Drug Development

Executive Summary

Synthetic biology offers opportunity across many industries, but the ultimate prize may be health care. The millions of dollars investors have poured into companies developing CAR-T cell therapies and gene editing technologies points to growing confidence in the power of gene manipulation to generate novel, approvable therapeutics, even if for now these are just the early steps toward creating fully synthetic organisms.

Advertisement

Related Content

Can Artificial Intelligence Help Find Better Medicines?
Cell Design Labs Envisions Robot Control of Tomorrow's CAR-T Therapies
Juno ROCKETs On Fast Clinical Hold Resolution
Nestlé Gets Serious With Seres Deal
Synlogic Links Up With AbbVie For IBD Microbiome Therapies
Kite And Juno Threatened By Cellectis' Off-The-Shelf CAR-T Success
Well-Funded Seres Races To Be First To Market With A Microbiome Drug
Mining The Microbiome: Are Gut Microbes The Next Big Source Of Drugs?

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV004935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel